Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Dmitry Nosov"'
Autor:
Alexandra Lebedeva, Olesya Kuznetsova, Maxim Ivanov, Alexandra Kavun, Egor Veselovsky, Ekaterina Belova, Vladislav Mileyko, Valentina Yakushina, Polina Shilo, Alexey Tryakin, Alexey Rumyantsev, Fedor Moiseenko, Mikhail Fedyanin, Dmitry Nosov
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e30303- (2024)
Genomic profiling, or molecular profiling of the tumor, is becoming a key component of therapeutic decision making in clinical oncology, and is typically carried out via next generation sequencing. However, the interpretation of the results and evalu
Externí odkaz:
https://doaj.org/article/7718f5a3b252465981cb2c0b26fb09e4
Autor:
Elizaveta Polyanskaya, Alexandra Lebedeva, Olesya Kuznetsova, Ekaterina Belova, Alexandra Kavun, Maxim Ivanov, Mikhail Fedyanin, Alexey Tryakin, Vladislav Mileyko, Dmitry Nosov
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Colorectal cancer (CRC) is currently one of the most common tumor types diagnosed worldwide. In the early stages, the disease responds well to surgical and chemotherapeutic treatment, but in the later stages when therapeutic options are exhausted, co
Externí odkaz:
https://doaj.org/article/1d2c8448ae5e4200969af1ec70e054f3
Publikováno v:
Вопросы образования, Iss 2, Pp 199-225 (2019)
Being members of the Central Subject-Specific Methodology Board for the Russian School Student Olympiad in Social Theory and members of the jury for its final round, we discuss the specific aspects of teaching social theory at school and preparing fo
Externí odkaz:
https://doaj.org/article/cc51b6418c8445fca788e6480118060c
Autor:
Michael B. Atkins, Dmitry Nosov, Lina Yin, L Rhoda Molife, Thomas Powles, Sergio J Azevedo, Jens Bedke, Satoshi Tamada, Elizabeth R. Plimack, Rustem Gafanov, Brian I. Rini, Delphine Borchiellini, Bohuslav Melichar, Denis Soulières, Ihor Vynnychenko, Mei Chen, Frédéric Pouliot, Viktor Stus, Raymond S. McDermott, T. Waddell
Publikováno v:
The Lancet Oncology. 21:1563-1573
The first interim analysis of the KEYNOTE-426 study showed superior efficacy of pembrolizumab plus axitinib over sunitinib monotherapy in treatment-naive, advanced renal cell carcinoma. The exploratory analysis with extended follow-up reported here a
Autor:
Alexandra Lebedeva, Maxim Ivanov, Olesya Kuznetsova, Margarita Sharova, Ekaterina Ignatova, Alexey Tryakin, Vladislav Mileyko, Mikhail Fedyanin, Dmitry Nosov
Publikováno v:
Journal of Clinical Oncology. 40:e18623-e18623
e18623 Background: As precision oncology evolves, a growing number of physicians refer cancer patients for CTMP. Oftentimes, CTMP cannot be performed at local centers and patients turn to third-party facilities or commercial solutions. CTMP findings
Autor:
Igor Bondarenko, Viktor Stus, Jens Bedke, Ihor Vynnychenko, Mei Chen, Anna Kryzhanivska, Rustem Gafanov, Qiong Shou, Robert E. Hawkins, Maurice Markus, Sergio J Azevedo, Raymond S. McDermott, Rodolfo F. Perini, Brian I. Rini, Denis Soulières, Dmitry Nosov, Yen-Hwa Chang, Sophie Tartas, Satoshi Tamada, Delphine Borchiellini, Bohuslav Melichar, Frédéric Pouliot, Elizabeth R. Plimack, Thomas Powles, Cezary Szczylik, Michael B. Atkins, Boris Alekseev
Publikováno v:
BASE-Bielefeld Academic Search Engine
Background The combination of pembrolizumab and axitinib showed antitumor activity in a phase 1b trial involving patients with previously untreated advanced renal-cell carcinoma. Whether pembrolizumab plus axitinib would result in better outcomes tha
Publikováno v:
Written Monuments of the Orient. 4:96-123
Autor:
Dmitry Nosov, Katriina Peltolta, Robert J. Motzer, Cora N. Sternberg, C. Szczylik, Nizar M. Tannir, Toni K. Choueiri, Bernard Escudier, Bohuslav Melichar, Douglas O. Clary, Christian Scheffold, Patrick Schöffski, Thomas Powles, Viktor Grünwald, Frede Donskov, Manuela Schmidinger
Publikováno v:
Tannir, N M, Powles, T, Escudier, B, Donskov, F, Grünwald, V, Sternberg, C N, Schmidinger, M, Schöffski, P, Szczylik, C, Peltolta, K, Nosov, D, Melichar, B, Clary, D, Scheffold, C, Motzer, R J & Choueiri, T K 2020, ' Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma ', Kidney Cancer, vol. 4, no. 1, pp. 29-39 . https://doi.org/10.3233/KCA-190080
Background: We investigated outcomes with cabozantinib versus everolimus in patients with advanced renal cell carcinoma (RCC) with or without prior nephrectomy in the phase 3 METEOR trial (NCT01865747). Methods: Patients (N = 658) with advanced clear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff64793d16ffc862973f6fff75484bb8
Autor:
Ilya Tsimafeyeu, Sergei Tjulandin, Catherine Degnin, Oleg Gladkov, Charles R. Thomas, Dmitry Nosov, Sergey Usychkin, Timur Mitin, Natalia Dengina, Yiyi Chen, Marina Chernykh
Publikováno v:
Journal of cancer education : the official journal of the American Association for Cancer Education. 36(5)
Trimodality bladder preservation (BP) is an accepted alternative to radical cystectomy for patients with muscle invasive bladder cancer (MIBC). The global utilization of BP is variable, and practice patterns have not been previously studied in Russia
Autor:
Oleg Lipatov, Tim Eisen, Cora N. Sternberg, Thomas E. Hutson, Piotr Tomczak, Robert J. Motzer, Ana M. Molina, Dmitry Nosov
Publikováno v:
European journal of cancer (Oxford, England : 1990)
Background Tivozanib is a selective inhibitor of vascular endothelial growth factor receptors 1, 2 and 3 tyrosine kinases. This open-label, crossover clinical study (AV-951-09-902) provided access to tivozanib for patients who progressed on sorafenib